Ausgabe 5/2021
Inhalt (13 Artikel)
- Multiple Myeloma (P Kapoor, Section Editor)
Targeting BCMA in Multiple Myeloma
Carlyn Rose Tan, Urvi A. Shah
- Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors)
Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses
Kathryn A. F. Kline, Michael E. Kallen, Vu H. Duong, Jennie Y. Law
- Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors)
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia
Ahmed Aleem, Ali R. Haque, Gregory W. Roloff, Elizabeth A. Griffiths
- Myelodysplastic Syndromes and MPN/MDS Overlap (M Patnaik, Section Editor)
Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia
Danielle Hammond, Guillermo Montalban-Bravo
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Elevating Twitter-Based Journal Club Discussions by Leveraging a Voice-Based Platform: #HemepathJC Meets Clubhouse
Aadil Ahmed, Kamran M. Mirza, Sanam Loghavi
- Chronic Lymphocytic Leukemias (N Jain, Section Editor)
BTK Inhibitors in Chronic Lymphocytic Leukemia
Sameh Gaballa, Javier Pinilla-Ibarz
- Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)
Treatment-Free Remission: the New Goal in CML Therapy
Ehab Atallah, Kendra Sweet
- Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)
Challenges in Chronic Myeloid Leukemia Management in South America
Katia B. Pagnano, Ana Ines Varela, Carolina Pavlovsky, Israel Bendit, Vaneuza A. M. Funke, Virginia Abello Polo
- Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)
The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
Heather R. Wolfe, Lindsay A. M. Rein
- Zur Zeit gratis
- COVID-19
- Myeloproliferative Neoplasms (BL Stein, Section Editor)
Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic
Tiziano Barbui, Valerio De Stefano
- Myeloproliferative Neoplasms (BL Stein, Section Editor)
Avapritinib in the Treatment of Systemic Mastocytosis: an Update
Samantha Below, Laura C. Michaelis
- Myeloproliferative Neoplasms (BL Stein, Section Editor)
Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
Joan How, Gabriela Hobbs
- Myeloproliferative Neoplasms (BL Stein, Section Editor)
Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials
Brady L. Stein
